3SBio Inc
HKEX:1530

Watchlist Manager
3SBio Inc Logo
3SBio Inc
HKEX:1530
Watchlist
Price: 23.82 HKD 0.93% Market Closed
Market Cap: HK$58B

Profitability Summary

3SBio Inc's profitability score is 57/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

57/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

57/100
Profitability
Score
57/100
Profitability
Score

Margins

Earnings Waterfall
3SBio Inc

Margins Comparison
3SBio Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
3SBio Inc
HKEX:1530
56.1B HKD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
394.5B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.9B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
173.7B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
122.4B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.5B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
88.6B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
44.1B EUR
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.6B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
3SBio Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
3SBio Inc
HKEX:1530
56.1B HKD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
394.5B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.9B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
173.7B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
122.4B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.5B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
88.6B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
44.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.6B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
3SBio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate